i am open to any criticism, but please did you bother to read part 2 of the Chantix summary....here it is below..just in case. you can read it in the second part of the article. thanks
FDA Advisory
Last month, the FDA approved safety-labeling modifications for varenicline tartrate tablets (Chantix, Pfizer, Inc) that include a black-box warning regarding the risk for severe neuropsychiatric symptoms. The possible neuropsychiatric problems that can occur include depression, mania, psychosis, hallucinations, paranoia, delusions, homicidal ideation, hostility, agitation, anxiety
Comment Reply
i am open to any criticism, but please did you bother to read part 2 of the Chantix summary....here it is below..just in case. you can read it in the second part of the article. thanks
FDA Advisory
Last month, the FDA approved safety-labeling modifications for varenicline tartrate tablets (Chantix, Pfizer, Inc) that include a black-box warning regarding the risk for severe neuropsychiatric symptoms. The possible neuropsychiatric problems that can occur include depression, mania, psychosis, hallucinations, paranoia, delusions, homicidal ideation, hostility, agitation, anxiety
September 5, 2009 - 5:56amThis Comment
Reply